Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price ...

Viridian Metals has expanded its land holdings in the Seal Basin, Labrador, by securing 2,600km² through staking. This acquisition makes Viridian the largest claim holder in Newfoundland and Labrador, ...

Thyroid eye disease (TED) therapy Tepezza – the biggest asset in Amgen's $26 billion takeover of Horizon last year – could soon face competition from a drug in the same class from Viridian ...

Viridian Metals Inc. (TSXV: VRDN) ("Viridian or the "Company") is pleased to announce that it has received the approval of ...

Leerink Partners analyst Thomas Smith has maintained their bullish stance on VRDN stock, giving a Buy rating on January 14.Invest with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Canadian Securities Exchange ("CSE" or "the Exchange") today welcomed the listing of Viridian Metals Inc. ("Viridian" or ...

Australia’s only maker of specialist glass, whose products were used in Canberra’s Parliament House, could not compete with ...

Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the company, Ratings ...